Location: Boston, MA
CIK: 0001583977 · Show all filings
Period: Q2 2015 (← Previous) (Next →)
Filing Date: Aug 14, 2015
Total Value: $752M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ALKS | ALKERMES PLC | 700,000 | $45.04M | 6.0% | $56.67 | +8.0% | SHS | G01767105 |
| HRTX | HERON THERAPEUTICS INC | 1,440,000 | $44.87M | 6.0% | $12.49 | +50.6% | COM | 427746102 |
| — | RECEPTOS INC | 220,000 | $41.81M | 5.6% | $43.18 | — | COM | 756207106 |
| — | ALDER BIOPHARMACEUTICALS INC | 757,475 | $40.12M | 5.3% | $41.16 | — | COM | 014339105 |
| — | DYAX CORP | 1,400,000 | $37.1M | 4.9% | $11.07 | — | COM | 26746E103 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 718,900 | $34.34M | 4.6% | $15.30 | +177.2% | COM | 64125C109 |
| SRNE | SORRENTO THERAPEUTICS INC | 1,945,334 | $34.28M | 4.6% | $8.64 | +48.8% | COM NEW | 83587F202 |
| EGRX | EAGLE PHARMACEUTICALS INC | 300,000 | $24.26M | 3.2% | $20.11 | +223.9% | COM | 269796108 |
| ARDX | ARDELYX INC | 1,481,075 | $23.65M | 3.1% | $17.63 | -28.5% | COM | 039697107 |
| — | PORTOLA PHARMACEUTICALS INC | 500,000 | $22.77M | 3.0% | $27.49 | — | COM | 737010108 |
| — | NOVAVAX INC | 1,600,000 | $17.82M | 2.4% | $6.35 | — | COM | 670002104 |
| — | TESARO INC | 291,250 | $17.12M | 2.3% | $38.73 | — | COM | 881569107 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 140,000 | $16.78M | 2.2% | $119.50 | 0.0% | COM | 02043Q107 |
| — | QUOTIENT LTD | 1,119,100 | $16.55M | 2.2% | $13.68 | — | SHS | G73268107 |
| CHRS | COHERUS BIOSCIENCES INC | 569,130 | $16.45M | 2.2% | $20.98 | +20.5% | COM | 19249H103 |
| — | ADVAXIS INC | 800,000 | $16.26M | 2.2% | $7.24 | — | COM NEW | 007624208 |
| — | AGENUS INC | 1,559,000 | $13.45M | 1.8% | $4.54 | — | COM NEW | 00847G705 |
| — | CHINA BIOLOGIC PRODS INC | 111,500 | $12.84M | 1.7% | $66.66 | — | COM | 16938C106 |
| DXCM | DEXCOM INC | 153,000 | $12.24M | 1.6% | $7.91 | +121.9% | COM | 252131107 |
| — | PFENEX INC | 624,900 | $12.12M | 1.6% | $16.77 | — | COM | 717071104 |
| — | DYNAVAX TECHNOLOGIES CORP | 500,000 | $11.71M | 1.6% | $23.43 | — | COM NEW | 268158201 |
| — | NEVRO CORP | 208,500 | $11.21M | 1.5% | $53.14 | — | COM | 64157F103 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 102,000 | $10.44M | 1.4% | $46.32 | +67.6% | COM | 90400D108 |
| BCRX | BIOCRYST PHARMACEUTICALS | 680,000 | $10.15M | 1.3% | $9.67 | +17.6% | COM | 09058V103 |
| — | RECRO PHARMA INC | 780,000 | $10.08M | 1.3% | $7.16 | — | COM | 75629F109 |
| — | REGULUS THERAPEUTICS INC | 896,522 | $9.826M | 1.3% | $14.62 | — | COM | 75915K101 |
| — | FORWARD PHARMA A/S | 255,000 | $9.703M | 1.3% | $23.92 | — | SPONSORED ADR | 34986J105 |
| — | CURIS INC | 2,632,000 | $8.712M | 1.2% | $2.28 | — | COM | 231269101 |
| — | KERYX BIOPHARMACEUTICALS INC | 826,000 | $8.243M | 1.1% | $13.75 | — | COM | 492515101 |
| — | KARYOPHARM THERAPEUTICS INC | 300,987 | $8.19M | 1.1% | $33.09 | — | COM | 48576U106 |
| COLL | COLLEGIUM PHARMACEUTICAL INC | 450,000 | $8.028M | 1.1% | $17.29 | 0.0% | COM | 19459J104 |
| — | OVASCIENCE INC | 252,180 | $7.296M | 1.0% | $25.13 | — | COM | 69014Q101 |
| OMER | OMEROS CORP | 388,500 | $6.989M | 0.9% | $12.81 | +68.5% | COM | 682143102 |
| — | MINERVA NEUROSCIENCES INC | 1,145,053 | $6.641M | 0.9% | $5.16 | — | COM | 603380106 |
| — | EPIZYME INC | 266,250 | $6.39M | 0.8% | $18.78 | — | COM | 29428V104 |
| — | ACCELERON PHARMA INC | 200,000 | $6.328M | 0.8% | $32.04 | — | COM | 00434H108 |
| — | ARRAY BIOPHARMA INC | 850,000 | $6.129M | 0.8% | $5.01 | — | COM | 04269X105 |
| — | LIPOCINE INC NEW | 666,666 | $5.72M | 0.8% | $6.90 | — | COM | 53630X104 |
| — | APTOSE BIOSCIENCES INC | 1,081,867 | $5.542M | 0.7% | $5.91 | — | COM NEW | 03835T200 |
| — | ROCKWELL MEDICAL INC | 340,000 | $5.481M | 0.7% | $12.66 | — | COM | 774374102 |
| — | EPIRUS BIOPHARMACEUTICALS IN | 896,600 | $5.12M | 0.7% | $8.68 | — | COM | 29428P107 |
| — | NEKTAR THERAPEUTICS | 397,500 | $4.973M | 0.7% | $12.07 | — | COM | 640268108 |
| — | LION BIOTECHNOLOGIES INC | 499,815 | $4.583M | 0.6% | $11.67 | — | COM | 53619R102 |
| — | KITE PHARMA INC | 68,800 | $4.195M | 0.6% | $46.23 | — | COM | 49803L109 |
| SGMO | SANGAMO BIOSCIENCES INC | 361,000 | $4.003M | 0.5% | $17.13 | -24.7% | COM | 800677106 |
| — | IMMUNE DESIGN CORP | 189,000 | $3.903M | 0.5% | $18.77 | — | COM | 45252L103 |
| — | CELYAD SA | 75,000 | $3.902M | 0.5% | $52.03 | — | ADR | 151205200 |
| — | GLYCOMIMETICS INC | 458,955 | $3.649M | 0.5% | $16.33 | — | COM | 38000Q102 |
| — | ACELRX PHARMACEUTICALS INC | 850,000 | $3.604M | 0.5% | $9.56 | — | COM | 00444T100 |
| — | DICERNA PHARMACEUTICALS INC | 245,000 | $3.418M | 0.5% | $15.70 | — | COM | 253031108 |
| — | DERMIRA INC | 170,000 | $2.984M | 0.4% | $18.11 | — | COM | 24983L104 |
| — | TETRALOGIC PHARMACEUTICAL C | 5,000,000 | $2.978M | 0.4% | $0.60 | — | NOTE 8.000% 6/1 | 88165UAB5 |
| FOLD | AMICUS THERAPEUTICS INC | 200,000 | $2.83M | 0.4% | $12.02 | 0.0% | COM | 03152W109 |
| — | AVEO PHARMACEUTICALS INC | 1,587,715 | $2.763M | 0.4% | $1.74 | — | COM | 053588109 |
| — | BLUEPRINT MEDICINES CORP | 100,000 | $2.649M | 0.4% | $26.49 | — | COM | 09627Y109 |
| — | ATARA BIOTHERAPEUTICS INC | 50,000 | $2.638M | 0.4% | $52.76 | — | COM | 046513107 |
| — | VERSARTIS INC | 170,000 | $2.587M | 0.3% | $28.04 | — | COM | 92529L102 |
| — | CERULEAN PHARMA INC | 551,354 | $2.536M | 0.3% | $5.47 | — | COM | 15708Q105 |
| — | GENVEC INC | 1,176,235 | $2.4M | 0.3% | $2.65 | — | COM NEW | 37246C307 |
| — | HTG MOLECULAR DIAGNOSTICS IN | 201,000 | $2.241M | 0.3% | $11.15 | — | COM | 40434H104 |
| — | KINDRED BIOSCIENCES INC | 328,497 | $2.24M | 0.3% | $11.93 | — | COM | 494577109 |
| — | SERES THERAPEUTICS INC | 50,000 | $2.075M | 0.3% | $41.50 | — | COM | 81750R102 |
| — | AQUINOX PHARMACEUTICALS INC | 279,900 | $1.943M | 0.3% | $12.15 | — | COM | 03842B101 |
| — | AGILE THERAPEUTICS INC | 182,053 | $1.564M | 0.2% | $8.82 | — | COM | 00847L100 |
| VCYT | VERACYTE INC | 137,990 | $1.537M | 0.2% | $7.94 | +23.9% | COM | 92337F107 |
| — | CELLECTAR BIOSCIENCES INC | 530,000 | $1.526M | 0.2% | $2.22 | — | COM NEW | 15117F203 |
| — | NANOSTRING TECHNOLOGIES INC | 80,000 | $1.234M | 0.2% | $20.65 | — | COM | 63009R109 |
| — | CONTRAFECT CORP | 234,406 | $1.231M | 0.2% | $5.25 | — | COM | 212326102 |
| PVCT | PROVECTUS BIOPHARMACEUTICALS | 2,200,000 | $1.188M | 0.2% | $0.82 | 0.0% | COM | 74373P108 |
| ASND | ASCENDIS PHARMA A S | 61,500 | $1.087M | 0.1% | $17.35 | — | SPNSORED ADR | 04351P101 |
| AKBA | AKEBIA THERAPEUTICS INC | 100,300 | $1.032M | 0.1% | $24.08 | -64.6% | COM | 00972D105 |
| — | BIOTIE THERAPIES OYJ | 50,000 | $999K | 0.1% | $19.98 | — | SPONSORED ADR | 09074D103 |
| — | SCYNEXIS INC | 99,366 | $873K | 0.1% | $8.02 | — | COM | 811292101 |
| GALT | GALECTIN THERAPEUTICS INC | 286,200 | $781K | 0.1% | $13.23 | -77.2% | COM NEW | 363225202 |
| — | PROVECTUS BIOPHARMACEUTICALS | 2,200,000 | $480K | 0.1% | $0.22 | — | *W EXP 06/24/202 | 74373P116 |
| ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | 25,000 | $458K | 0.1% | $18.32 | — | SPONDS ADR | 00653A107 |
| — | CELLECTAR BIOSCIENCES INC | 530,000 | $413K | 0.1% | $0.60 | — | *W EXP 08/19/201 | 15117F112 |
| CLLS | CELLECTIS S A | 11,300 | $408K | 0.1% | $34.60 | — | SPONSORED ADS | 15117K103 |
| — | APPLIED GENETIC TECHNOL CORP | 17,110 | $262K | 0.0% | $23.10 | — | COM NEW | 03820J100 |
| — | CELSUS THERAPEUTICS PLC | 286,508 | $166K | 0.0% | $5.99 | — | SPONSORED ADR NE | 15119A202 |